IRIS Accounts Production v23.3.1.45 09986050 Board of Directors Board of Directors Board of Directors 1.3.22 28.2.23 28.2.23 false true false false true false Ordinary shares 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh099860502022-02-28099860502023-02-28099860502022-03-012023-02-28099860502021-02-28099860502021-03-012022-02-28099860502022-02-2809986050ns10:Originalns15:EnglandWales2022-03-012023-02-2809986050ns14:PoundSterlingns10:Original2022-03-012023-02-2809986050ns10:Originalns10:Director12022-03-012023-02-2809986050ns10:Original2022-03-012023-02-2809986050ns10:Originalns10:Director22022-03-012023-02-2809986050ns10:Originalns10:Director32022-03-012023-02-2809986050ns10:Original2023-02-2809986050ns10:Originalns10:PrivateLimitedCompanyLtd2022-03-012023-02-2809986050ns10:Originalns10:SmallEntities2022-03-012023-02-2809986050ns10:Originalns10:AuditExempt-NoAccountantsReport2022-03-012023-02-2809986050ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2022-03-012023-02-2809986050ns10:SmallCompaniesRegimeForAccountsns10:Original2022-03-012023-02-2809986050ns10:Originalns10:FullAccounts2022-03-012023-02-2809986050ns10:Originalns10:OrdinaryShareClass12022-03-012023-02-2809986050ns10:Original2022-02-2809986050ns10:Originalns5:CurrentFinancialInstruments2023-02-2809986050ns10:Originalns5:CurrentFinancialInstruments2022-02-2809986050ns5:ShareCapitalns10:Original2023-02-2809986050ns5:ShareCapitalns10:Original2022-02-2809986050ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-02-2809986050ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-02-2809986050ns10:Originalns10:RegisteredOffice2022-03-012023-02-2809986050ns10:Original2021-03-012022-02-2809986050ns10:Originalns5:FurnitureFittings2022-02-2809986050ns10:Originalns5:FurnitureFittings2022-03-012023-02-2809986050ns10:Originalns5:FurnitureFittings2023-02-2809986050ns10:Originalns5:FurnitureFittings2022-02-2809986050ns10:Originalns10:OrdinaryShareClass12023-02-2809986050ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-02-2809986050ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-03-012023-02-28
REGISTERED NUMBER: 09986050 (England and Wales)















Unaudited Financial Statements for the Year Ended 28 February 2023

for

Care And Cure Limited

Care And Cure Limited (Registered number: 09986050)






Contents of the Financial Statements
for the Year Ended 28 February 2023




Page

Balance Sheet 1

Notes to the Financial Statements 3


Care And Cure Limited (Registered number: 09986050)

Balance Sheet
28 February 2023

28.2.23 28.2.22
Notes £ £
Fixed assets
Tangible assets 4 938 1,251

Current assets
Debtors 5 170,000 170,001
Cash at bank 58,597 63,801
228,597 233,802
Creditors
Amounts falling due within one year 6 (40,374 ) (21,271 )
Net current assets 188,223 212,531
Total assets less current liabilities 189,161 213,782

Capital and reserves
Called up share capital 7 100 100
Retained earnings 8 189,061 213,682
Shareholders' funds 189,161 213,782

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 28 February 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 28 February 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Care And Cure Limited (Registered number: 09986050)

Balance Sheet - continued
28 February 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 29 November 2023 and were signed on its behalf by:




Dr Mamoona Ashraf - Director Dr Fawad Ali - Director




Dr Madeeha Noureen - Director


Care And Cure Limited (Registered number: 09986050)

Notes to the Financial Statements
for the Year Ended 28 February 2023

1. Statutory information

Care And Cure Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 09986050

Registered office: Marshall House, Suite 21/25
124 Middleton Road
Morden
SM4 6RW

2. Accounting policies

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. Employees and directors

The average number of employees during the year was 2 (2022 - 2 ) .

Care And Cure Limited (Registered number: 09986050)

Notes to the Financial Statements - continued
for the Year Ended 28 February 2023

4. Tangible fixed assets
Fixtures
and
fittings
£
Cost
At 1 March 2022
and 28 February 2023 7,024
Depreciation
At 1 March 2022 5,773
Charge for year 313
At 28 February 2023 6,086
Net book value
At 28 February 2023 938
At 28 February 2022 1,251

5. Debtors: amounts falling due within one year
28.2.23 28.2.22
£ £
Other debtors 170,000 170,001

6. Creditors: amounts falling due within one year
28.2.23 28.2.22
£ £
Trade creditors - 1
Corporation tax 40,374 21,270
40,374 21,271

7. Called up share capital

Allotted, issued and fully paid:
Number: Class: Nominal 28.2.23 28.2.22
value: £ £
100 Ordinary shares 1 100 100

Care And Cure Limited (Registered number: 09986050)

Notes to the Financial Statements - continued
for the Year Ended 28 February 2023

8. Reserves
Retained
earnings
£

At 1 March 2022 213,682
Profit for the year 171,806
Dividends (196,427 )
At 28 February 2023 189,061